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INTRODUCTION
Sjögren’s syndrome (SS) is a chronic inflammatory autoim-
mune disease characterized by progressive lymphocytic infil-
tration of the exocrine glands and other extra-glandular struc-
tures [1]. Dryness of the eyes (xerophthalmia leading to kera-
toconjunctivitis sicca) and mouth (xerostomia) constitute the 
typical clinical condition of this syndrome [1,2]. SS may also 
cause chronic multiple lymphadenopathy due to its lymphop-
roliferative characteristics. Although patients with SS have a 
lifespan not significantly different from that of the normal pop-
ulation, these patients carry a greater risk of developing lym-
phoproliferative malignancy [3]. In addition, other organ ma-
lignancies can also occur in patients with SS such as lung, breast, 
gastrointestinal, gynecological, renal, and skin cancers [3,4]. 
Considering all these, the diagnosis of breast cancer in patients 
with SS can be mistaken as cancer at an advanced stage par-
ticularly in the presence of axillary multiple lymph nodes.
In this study, we report a very rare case of breast cancer asso-
ciated with SS in which the cancer was overstaged and, thus, 
overtreated on the assumption of clinically positive axillary 
lymph node status.
CASE REPORT
A 45-year-old woman with a 12-year history of SS presented 
with a complaint of a breast mass. A breast examination revealed 
a palpable mass, measuring 10 cm in diameter, located in the 
upper lateral quadrant of the right breast and right axillary mul-
tiple lymph nodes. On ultrasonography, the mass was a 4 cm 
solid lesion located in heterogeneous breast parenchyma, and 
conglomerates of multiple axillary lymphadenopathy suspi-
cious of malignancy were also detected (Figure 1). The mam-
mography was almost normal due to the dense parenchymal 
pattern, except for the presence of the axillary lymphadenopa-
thy (Figure 2). A core-needle biopsy was performed on the breast 
lesion, and the diagnosis of ductal carcinoma in situ (DCIS) was 
made preoperatively. Based on the clinical suspicion of an     
advanced-stage breast cancer, the patient underwent a modi-
fied radical mastectomy. On postoperative histopathological 
assessment, the diagnosis of 8-cm high-grade DCIS was estab-
lished, however no axillary lymph node metastases were de-
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Sjögren’s syndrome (SS) is an autoimmune disease that chronic 
inflammation and lymph node proliferation. Patients with SS carry 
a greater risk of developing lymphoproliferative malignancy. In 
addition to other organ cancers, breast cancer may also occur in 
these patients. Considering these, breast cancer in patients with 
SS can be misdiagnosed as being in an advanced stage particu-
larly in the presence of axillary lymphadenopathy. Here, we report 
a rare case of a 45-year-old woman with SS who presented with 
a breast mass. Radiology showed a 4 cm solid lesion and con-
glomerates of axillary lymphadonepathy. A breast biopsy revealed 
ductal carcinoma in situ. A modified radical mastectomy was per-
formed; however, no axillary metastases were detected. Clinicians 
should remain vigilant to the possibility that a false clinical impres-
sion of axillary metastasis may occur in such patients with breast 
cancer. Therefore, axillary node status should be verified first.
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tected (Figure 3).
DISCUSSION
SS is an autoimmune disease that causes chronic inflamma-
tion and primarily affects the exocrine glands [1,2]. Because it 
is a systemic disease, SS can also exhibit a wide range of clinical 
manifestations. Among these, benign or malignant lymphop-
roliferation due to infiltration by lymphocytes and plasma cells 
may be a prominent part of this syndrome [5]. Several studies 
have shown a high incidence of malignancy in SS, the most 
common being lymphoma [3,4]. Other non-lymphoid cancers 
including breast cancer can also occur in patients with this syn-
drome; however, an increase in the incidence of these cancers 
has not been demonstrated. Lazarus et al. [4] reported on a 
retrospective cohort study of 112 patients with SS in whom 25 
developed malignancies, including three cases of breast can-
cer. In a recent study reported by Zhang et al. [3], malignancy 
was detected in 29 (2.2%) of 1,320 patients with SS, including 
four patients with breast cancer.
The preoperative diagnosis of breast cancer in the presented 
patient with SS was established by radiological evaluation fol-
lowed by breast biopsy. Lesion morphology, mammary gland 
density, and the lack of imaging technique skills may limit the 
sensitivity for detecting breast cancer. As such, mammography 
may not demonstrate up to 20-30% of malignancies in a dense 
breast pattern [6,7], as we encountered in the present case. 
Although the incidence of axillary metastases in patients with 
DCIS is small, the evidence of axillary lymph node conglom-
erates on both physical and radiological examinations in this 
case led us to a clinical impression of a metastatic or ‘‘N2’’ dis-
ease in the TNM staging definition [8], and that is why axillary 
dissection, in addition to a mastectomy, was performed. But, 
no axillary metastases were observed on the histopathology 
results. This clinically positive but pathologically negative node 
status was then attributed to the SS. We reviewed the literature 
and did not find any report regarding the management of such 
patients with SS presenting with breast cancer and an axillary 
clinicopathological discrepancy. We recommend that lymph 
node status be verified either pre- or intra-operatively by lymph 
node biopsy using either fine-needle, core-needle, or frozen-
section procedures before establishing a definitive diagnosis 
and appropriate surgical treatment. 
In conclusion, clinicians should remain vigilant to the pos-
sibility of overstaged breast cancer due to the false clinical im-
pression of axillary metastasis in patients with SS presenting 
Figure 1. Ultrasonographic appearance of the breast mass. The mass 
is a hypoechogenic lesion with irregular margins measuring 4 cm in di-
ameter. 
Figure 2. Mammography of 
the right breast (mediolateral 
oblique view). Mammogra- 
phic sensitivity decreased 
due to the increased density 
of the fibroglandular breast 
tissue.
Figure 3. Histopathological appearance of high-grade ductal carcinoma 
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with breast cancer. Therefore, axillary node status should be 
verified first to correctly establish tumor stage in this very rare 
clinical situation.
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